TissueGene Inc.

Advanced Cell Therapies for Orthopedic Disorders

Utilizing cell and gene therapy to develop novel drugs.

Osteoarthritis
Knee
R&D Pre-Clinical Phase I Phase II Phase III BLA Application
R&D Phase complete
Pre-Clinical Phase complete
Phase I Phase complete
Phase II Phase complete
Phase III Phase in progress
BLA Application Phase not started
Hand
R&D Pre-Clinical Phase I Phase II Phase III BLA Application
R&D Phase complete
Pre-Clinical Phase complete
Phase I Phase complete
Phase II Phase in progress
Phase III Phase not started
BLA Application Phase not started
Hip
R&D Pre-Clinical Phase I Phase II Phase III BLA Application
R&D Phase complete
Pre-Clinical Phase complete
Phase I Phase complete
Phase II Phase in progress
Phase III Phase not started
BLA Application Phase not started
Musculoskeletal System Disorder
Rheumatoid Arthritis
R&D Pre-Clinical Phase I Phase II Phase III BLA Application
R&D Phase complete
Pre-Clinical Phase in progress
Phase I Phase not started
Phase II Phase not started
Phase III Phase not started
BLA Application Phase not started
Meniscus
R&D Pre-Clinical Phase I Phase II Phase III BLA Application
R&D Phase complete
Pre-Clinical Phase in progress
Phase I Phase not started
Phase II Phase not started
Phase III Phase not started
BLA Application Phase not started
Spinal Disk
R&D Pre-Clinical Phase I Phase II Phase III BLA Application
R&D Phase complete
Pre-Clinical Phase in progress
Phase I Phase not started
Phase II Phase not started
Phase III Phase not started
BLA Application Phase not started
Vet Medicine
Knee
R&D Pre-Clinical Clinical Trial BLA Application
R&D Phase complete
Pre-Clinical Phase in progress
Clinical Trial Phase not started
BLA Application Phase not started

What is Osteoarthritis?

Osteoarthritis is a chronic disease caused by the progressive degeneration of articular cartilage and is characterized by joint pain, stiffness and limited movement.

Currently, it is estimated that osteoarthritis affects:

>33M adults in the U.S.
>111M adults worldwide*

With the increasing prevalence of osteoarthritis, driven primarily by the increasing aging population and obesity epidemic, a noninvasive treatment such as Invossa™ that treats not only the symptoms, but the causes of osteoarthritis is critical.

*7 major markets: US, France, Germany, Italy, Spain, UK and Japan